Coloplast A/S (OTCMKTS:CLPBY) Hits New 12-Month Low – Here’s Why

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) shares hit a new 52-week low on Tuesday . The stock traded as low as $5.65 and last traded at $5.71, with a volume of 563905 shares trading hands. The stock had previously closed at $5.75.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on CLPBY. The Goldman Sachs Group downgraded Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Coloplast A/S Stock Up 1.6%

The stock has a market capitalization of $13.05 billion, a PE ratio of 41.36, a price-to-earnings-growth ratio of 1.80 and a beta of 0.18. The company has a current ratio of 1.75, a quick ratio of 0.81 and a debt-to-equity ratio of 1.66. The company’s 50-day moving average is $6.23 and its 200 day moving average is $7.30.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.11 billion. Coloplast A/S had a net margin of 7.46% and a return on equity of 33.15%. As a group, analysts anticipate that Coloplast A/S Sponsored ADR will post 0.4 EPS for the current year.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.